SILDENAFIL

SILDENAFIL was reported 127803 times

SILDENAFIL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEART SOUNDS 33 0.3438
1 DEVICE WIRELESS COMMUNICATION ISSUE 87 0.3359
2 PULMONARY HYPERTENSIVE CRISIS 91 0.3358
3 HIGH RISK SEXUAL BEHAVIOUR 47 0.2597
4 CATHETER SITE IRRITATION 78 0.2342
5 CATHETER SITE PRURITUS 199 0.2267
6 DEVICE MAINTENANCE ISSUE 124 0.2109
7 CATHETER MANAGEMENT 173 0.1924
8 TRANSPLANT EVALUATION 94 0.1850
9 ATRIAL SEPTAL DEFECT REPAIR 30 0.1744
10 CATHETER SITE RASH 76 0.1681
11 VENTILATION PERFUSION MISMATCH 45 0.1601
12 PULMONARY ARTERIAL PRESSURE INCREASED 257 0.1577
13 CATHETER SITE ERYTHEMA 332 0.1550
14 CATHETER SITE DISCHARGE 171 0.1521
15 PULMONARY VENO-OCCLUSIVE DISEASE 106 0.1514
16 RIGHT VENTRICULAR FAILURE 1047 0.1493
17 WALKING DISTANCE TEST ABNORMAL 58 0.1483
18 PULMONARY ARTERIAL HYPERTENSION 2012 0.1387
19 OXYGEN CONSUMPTION INCREASED 315 0.1317
20 INFUSION SITE DISCHARGE 228 0.1299
21 PROLONGED EXPIRATION 33 0.1260
22 CATHETERISATION CARDIAC ABNORMAL 34 0.1259
23 RIGHT VENTRICULAR SYSTOLIC PRESSURE INCREASED 38 0.1199
24 INFUSION SITE INFECTION 278 0.1195
25 PULMONARY ARTERIAL PRESSURE ABNORMAL 33 0.1146
26 INFUSION SITE IRRITATION 145 0.1128
27 INFUSION SITE WARMTH 135 0.1101
28 CATHETER SITE SWELLING 102 0.1090
29 RIGHT VENTRICULAR DILATATION 60 0.1036
30 VASCULAR DEVICE OCCLUSION 35 0.1032
31 INFUSION SITE INDURATION 150 0.1011
32 INFUSION SITE HAEMORRHAGE 323 0.0981
33 INFUSION SITE VESICLES 50 0.0951
34 INFUSION SITE PAIN 1226 0.0950
35 CATHETER SITE PAIN 237 0.0913
36 LUNG TRANSPLANT 318 0.0897
37 PARACENTESIS 55 0.0894
38 INFUSION SITE INFLAMMATION 63 0.0892
39 INFUSION SITE DISCOLOURATION 78 0.0886
40 INFUSION SITE ERYTHEMA 746 0.0884
41 RIGHT VENTRICULAR DYSFUNCTION 95 0.0861
42 DEVICE INFUSION ISSUE 211 0.0850
43 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 117 0.0833
44 INFUSION SITE NODULE 79 0.0822
45 INFUSION SITE CELLULITIS 43 0.0814
46 HEART TRANSPLANT 73 0.0807
47 PULMONARY HYPERTENSION 1660 0.0796
48 CATHETER SITE INFLAMMATION 44 0.0782
49 INFUSION SITE DISCOMFORT 81 0.0781
50 INFUSION SITE ABSCESS 39 0.0774
51 CARDIOSPASM 43 0.0771
52 CATHETER SITE HAEMORRHAGE 190 0.0759
53 INFUSION SITE SWELLING 469 0.0745
54 DEVICE ALARM ISSUE 130 0.0715
55 CATHETERISATION CARDIAC 290 0.0653
56 HYPERVOLAEMIA 316 0.0639
57 INFUSION SITE PRURITUS 193 0.0611
58 PALMOPLANTAR KERATODERMA 43 0.0593
59 SYSTEMIC SCLERODERMA 43 0.0591
60 INFUSION SITE RASH 81 0.0590
61 SCLERODERMA 213 0.0585
62 DIZZINESS EXERTIONAL 44 0.0579
63 DYSPNOEA AT REST 160 0.0552
64 CATHETER PLACEMENT 100 0.0539
65 VASCULAR DEVICE INFECTION 242 0.0533
66 PAIN IN JAW 1488 0.0525
67 CATHETER SITE RELATED REACTION 38 0.0507
68 CHRONIC RESPIRATORY FAILURE 61 0.0505
69 COR PULMONALE 48 0.0503
70 INFUSION SITE REACTION 144 0.0482
71 RIGHT VENTRICULAR HYPERTROPHY 43 0.0476
72 CATHETER SITE INFECTION 179 0.0473
73 DYSCHROMATOPSIA 39 0.0470
74 CENTRAL VENOUS CATHETERISATION 142 0.0470
75 FLUID OVERLOAD 671 0.0461
76 ASPIRATION PLEURAL CAVITY 35 0.0455
77 INFUSION SITE OEDEMA 38 0.0455
78 INFUSION SITE MASS 49 0.0451
79 DYSPNOEA EXERTIONAL 1656 0.0439
80 SUTURE RELATED COMPLICATION 31 0.0438
81 BRAIN NATRIURETIC PEPTIDE INCREASED 131 0.0424
82 CARBON DIOXIDE INCREASED 57 0.0418
83 DEVICE CONNECTION ISSUE 87 0.0412
84 FLUID RETENTION 1992 0.0391
85 HEPATIC CONGESTION 37 0.0391
86 SUBSTANCE USE DISORDER 119 0.0373
87 DEVICE RELATED SEPSIS 75 0.0372
88 OXYGEN THERAPY 61 0.0371
89 PACKED RED BLOOD CELL TRANSFUSION 49 0.0370
90 TRANSFUSION 381 0.0363
91 ATRIAL TACHYCARDIA 76 0.0362
92 DERMATITIS CONTACT 407 0.0357
93 HAEMOGLOBIN INCREASED 162 0.0355
94 SEASONAL ALLERGY 492 0.0347
95 NOCTURNAL DYSPNOEA 42 0.0329
96 TRACHEOSTOMY 47 0.0329
97 OXYGEN SATURATION DECREASED 1837 0.0327
98 PURULENT DISCHARGE 139 0.0325
99 DEVICE POWER SOURCE ISSUE 93 0.0318
100 EXERCISE TOLERANCE DECREASED 178 0.0309
101 OXYGEN SATURATION ABNORMAL 86 0.0303
102 CARDIOVERSION 42 0.0300
103 INFUSION SITE BRUISING 63 0.0291
104 CHORIORETINOPATHY 41 0.0288
105 MECHANICAL VENTILATION 53 0.0279
106 PRIAPISM 96 0.0278
107 LYMPHOCYTE COUNT ABNORMAL 31 0.0275
108 ECHOCARDIOGRAM ABNORMAL 38 0.0271
109 DRUG TOLERANCE DECREASED 76 0.0270
110 HYPOXIA 953 0.0270
111 RHINOVIRUS INFECTION 103 0.0264
112 CONCOMITANT DISEASE AGGRAVATED 163 0.0264
113 CARDIAC ABLATION 47 0.0263
114 DEVICE RELATED INFECTION 402 0.0261
115 OPTIC ISCHAEMIC NEUROPATHY 97 0.0250
116 DIZZINESS POSTURAL 230 0.0237
117 ORTHOPNOEA 75 0.0235
118 RESPIRATION ABNORMAL 162 0.0235
119 ACUTE RESPIRATORY FAILURE 444 0.0231
120 LIVER TRANSPLANT 81 0.0223
121 RALES 128 0.0220
122 CONCOMITANT DISEASE PROGRESSION 43 0.0220
123 PULMONARY PAIN 62 0.0212
124 DRUG TITRATION ERROR 53 0.0205
125 CARDIAC FAILURE ACUTE 136 0.0204
126 STAPHYLOCOCCUS TEST POSITIVE 42 0.0199
127 ENDOTRACHEAL INTUBATION 55 0.0196
128 INTRA-ABDOMINAL FLUID COLLECTION 35 0.0195
129 THERAPY NON-RESPONDER 876 0.0195
130 LOCALISED OEDEMA 89 0.0192
131 NASAL CONGESTION 1128 0.0192
132 DEVICE OCCLUSION 267 0.0190
133 OEDEMA 1025 0.0189
134 CHOKING SENSATION 104 0.0188
135 PRURITUS GENITAL 44 0.0187
136 ATRIAL FLUTTER 147 0.0184
137 LEFT VENTRICULAR FAILURE 63 0.0183
138 PULMONARY OEDEMA 818 0.0182
139 VASODILATATION 46 0.0182
140 DISEASE COMPLICATION 83 0.0181
141 PERICARDIAL EFFUSION 418 0.0181
142 BLOOD PRESSURE SYSTOLIC DECREASED 82 0.0180
143 RETINAL ARTERY OCCLUSION 45 0.0178
144 PATIENT DISSATISFACTION WITH TREATMENT 34 0.0176
145 CARDIAC OPERATION 151 0.0175
146 WRONG DOSE 42 0.0174
147 CYANOSIS 273 0.0173
148 THERAPY CHANGE 170 0.0173
149 RETINAL VEIN OCCLUSION 49 0.0170
150 BLOOD CULTURE POSITIVE 51 0.0170
151 TRANSPLANT 40 0.0168
152 RESPIRATORY TRACT INFECTION VIRAL 39 0.0167
153 PRODUCT ADMINISTRATION INTERRUPTED 130 0.0165
154 COMPLICATION ASSOCIATED WITH DEVICE 238 0.0164
155 CARDIAC FAILURE CHRONIC 69 0.0162
156 INJECTION SITE INFECTION 53 0.0161
157 TENSION HEADACHE 69 0.0160
158 POLYCYTHAEMIA 33 0.0160
159 HYPERCAPNIA 48 0.0159
160 PRODUCTIVE COUGH 745 0.0156
161 THROMBOSIS IN DEVICE 51 0.0155
162 BLOOD LOSS ANAEMIA 35 0.0154
163 SUSPECTED COUNTERFEIT PRODUCT 61 0.0154
164 HAEMATOLOGICAL INFECTION 37 0.0151
165 HAEMOPTYSIS 414 0.0148
166 PULSELESS ELECTRICAL ACTIVITY 61 0.0146
167 RESPIRATORY SYNCYTIAL VIRUS INFECTION 127 0.0146
168 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 90 0.0146
169 PULMONARY HAEMORRHAGE 113 0.0144
170 DYSPNOEA 8090 0.0143
171 CARDIAC PACEMAKER INSERTION 85 0.0142
172 ASCITES 418 0.0142
173 PREMATURE DELIVERY 224 0.0141
174 MIDDLE EAR EFFUSION 31 0.0140
175 TACHYARRHYTHMIA 35 0.0140
176 PARANASAL SINUS DISCOMFORT 53 0.0140
177 CAROTID ARTERY OCCLUSION 51 0.0140
178 EMERGENCY CARE 42 0.0138
179 PAINFUL RESPIRATION 33 0.0137
180 EAR CONGESTION 37 0.0136
181 PARANASAL SINUS HYPERSECRETION 52 0.0136
182 SYNCOPE 1353 0.0135
183 CARDIAC FAILURE 1079 0.0134
184 FLUSHING 1357 0.0133
185 HERNIA REPAIR 34 0.0131
186 BLOOD PRESSURE DIASTOLIC ABNORMAL 33 0.0130
187 MACULOPATHY 46 0.0130
188 DEVICE FAILURE 197 0.0129
189 PRESYNCOPE 314 0.0129
190 HYPERPARATHYROIDISM SECONDARY 32 0.0128
191 TRICUSPID VALVE INCOMPETENCE 101 0.0127
192 RESPIRATORY FAILURE 923 0.0126
193 IDIOPATHIC PULMONARY FIBROSIS 50 0.0126
194 EPISTAXIS 945 0.0126
195 DIALYSIS 179 0.0126
196 SUDDEN CARDIAC DEATH 43 0.0126
197 OEDEMA PERIPHERAL 1533 0.0126
198 INJECTION SITE DISCHARGE 67 0.0124
199 HYPOTENSION 2493 0.0124
200 RESPIRATORY TRACT CONGESTION 197 0.0124
201 CARDIOMEGALY 151 0.0123
202 NASAL DRYNESS 75 0.0120
203 PRODUCT LEAKAGE 67 0.0119
204 SPUTUM DISCOLOURED 113 0.0119
205 SUBARACHNOID HAEMORRHAGE 121 0.0119
206 HEART VALVE INCOMPETENCE 34 0.0119
207 CARDIOPULMONARY FAILURE 46 0.0118
208 CARDIOGENIC SHOCK 168 0.0117
209 SINUS CONGESTION 157 0.0116
210 COUGH 3224 0.0115
211 THROAT IRRITATION 515 0.0115
212 PULMONARY CONGESTION 151 0.0114
213 HAEMODYNAMIC INSTABILITY 87 0.0114
214 ERECTILE DYSFUNCTION 293 0.0114
215 PULMONARY ALVEOLAR HAEMORRHAGE 64 0.0114
216 ERECTION INCREASED 46 0.0110
217 INTERNAL HAEMORRHAGE 125 0.0109
218 SLEEP TERROR 46 0.0109
219 GOUT 196 0.0109
220 LUNG DISORDER 532 0.0108
221 SECRETION DISCHARGE 135 0.0108
222 PREMATURE BABY 324 0.0108
223 FACIAL PAIN 96 0.0107
224 SINUS DISORDER 209 0.0105
225 IRON DEFICIENCY ANAEMIA 97 0.0105
226 INFUSION SITE EXTRAVASATION 65 0.0104
227 CARDIAC FAILURE CONGESTIVE 834 0.0104
228 NEPHROGENIC ANAEMIA 48 0.0104
229 CHEST PAIN 1914 0.0103
230 RESPIRATORY DISTRESS 285 0.0103
231 DEVICE PHYSICAL PROPERTY ISSUE 79 0.0103
232 VIRAL UPPER RESPIRATORY TRACT INFECTION 49 0.0103
233 CHEST DISCOMFORT 1047 0.0102
234 AMMONIA INCREASED 52 0.0102
235 DEVICE KINK 37 0.0101
236 PNEUMOTHORAX 161 0.0101
237 BLOOD IRON DECREASED 120 0.0101
238 CARDIAC TAMPONADE 48 0.0101
239 DEVICE DISLOCATION 438 0.0101
240 DIASTOLIC DYSFUNCTION 31 0.0100
241 ONYCHOMYCOSIS 44 0.0100
242 DECREASED ACTIVITY 108 0.0100
243 DEPRESSIVE SYMPTOM 35 0.0099
244 BLOOD PRESSURE DECREASED 659 0.0099
245 SUDDEN DEATH 104 0.0098
246 REHABILITATION THERAPY 38 0.0098
247 DEAFNESS NEUROSENSORY 32 0.0097
248 PERIPHERAL SWELLING 1499 0.0097
249 HEADACHE 6073 0.0097
250 HEAD DISCOMFORT 169 0.0095
251 FLANK PAIN 89 0.0095
252 GENERALISED OEDEMA 116 0.0094
253 HEART RATE ABNORMAL 52 0.0093
254 BLOOD POTASSIUM DECREASED 279 0.0093
255 SARCOIDOSIS 44 0.0093
256 PALPITATIONS 1081 0.0092
257 INCORRECT DRUG ADMINISTRATION RATE 39 0.0092
258 INTERNATIONAL NORMALISED RATIO DECREASED 37 0.0091
259 EAR DISCOMFORT 93 0.0091
260 SUPRAVENTRICULAR TACHYCARDIA 86 0.0090
261 HOSPICE CARE 88 0.0089
262 CARDIAC FLUTTER 57 0.0088
263 LOW BIRTH WEIGHT BABY 69 0.0087
264 DRY THROAT 88 0.0086
265 TERMINAL STATE 57 0.0085
266 CIRCULATORY COLLAPSE 145 0.0085
267 PLEURAL EFFUSION 518 0.0085
268 WEIGHT FLUCTUATION 89 0.0085
269 GASTROENTERITIS VIRAL 153 0.0085
270 PNEUMONIA 2743 0.0085
271 THERAPY PARTIAL RESPONDER 132 0.0085
272 LOCALISED INFECTION 201 0.0083
273 HEART RATE INCREASED 817 0.0082
274 BLOOD PRESSURE DIASTOLIC INCREASED 38 0.0082
275 SKIN LACERATION 89 0.0082
276 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 427 0.0082
277 SENSITIVITY TO WEATHER CHANGE 43 0.0082
278 FACE INJURY 31 0.0082
279 PULMONARY THROMBOSIS 89 0.0082
280 VIRAL INFECTION 270 0.0081
281 BACTERAEMIA 96 0.0081
282 STENT PLACEMENT 65 0.0081
283 POLYURIA 66 0.0081
284 STAPHYLOCOCCAL BACTERAEMIA 35 0.0080
285 NEUTROPHIL COUNT INCREASED 82 0.0080
286 UPPER RESPIRATORY TRACT INFECTION 370 0.0080
287 FAECES SOFT 58 0.0080
288 ATRIAL FIBRILLATION 776 0.0080
289 HAEMATOCRIT DECREASED 157 0.0079
290 OROPHARYNGEAL DISCOMFORT 71 0.0079
291 HOSPITALISATION 1203 0.0078
292 RETCHING 166 0.0078
293 IRON DEFICIENCY 35 0.0078
294 FAILURE TO THRIVE 40 0.0077
295 STAPHYLOCOCCAL SEPSIS 38 0.0077
296 RHINORRHOEA 495 0.0077
297 MULTIPLE ALLERGIES 60 0.0076
298 ACUTE PULMONARY OEDEMA 42 0.0075
299 RESPIRATORY RATE INCREASED 66 0.0074
300 HAEMORRHOIDAL HAEMORRHAGE 36 0.0074
301 TROPONIN INCREASED 56 0.0074
302 ABNORMAL LOSS OF WEIGHT 50 0.0073
303 DIARRHOEA 4714 0.0073
304 BREATH SOUNDS ABNORMAL 36 0.0073
305 RESPIRATORY DISORDER 218 0.0073
306 VENTRICULAR TACHYCARDIA 120 0.0073
307 ATELECTASIS 70 0.0072
308 BLOOD PRESSURE ABNORMAL 143 0.0072
309 NASAL DISCOMFORT 57 0.0072
310 CELLULITIS 361 0.0072
311 SKIN INFECTION 80 0.0071
312 HEPATOMEGALY 70 0.0071
313 SINUS HEADACHE 42 0.0071
314 DIZZINESS 3520 0.0071
315 HEPATIC CIRRHOSIS 132 0.0070
316 HEAD INJURY 222 0.0070
317 CARDIAC VALVE DISEASE 40 0.0070
318 BLOOD BILIRUBIN INCREASED 189 0.0070
319 PULMONARY FIBROSIS 134 0.0070
320 OROPHARYNGEAL PAIN 643 0.0069
321 APPETITE DISORDER 46 0.0069
322 VISUAL FIELD DEFECT 50 0.0069
323 UPPER-AIRWAY COUGH SYNDROME 57 0.0069
324 FOOD POISONING 37 0.0069
325 ANAL INCONTINENCE 62 0.0069
326 UNEVALUABLE EVENT 515 0.0068
327 MUSCULOSKELETAL CHEST PAIN 105 0.0068
328 CARDIAC ARREST 557 0.0067
329 FOETAL GROWTH RESTRICTION 41 0.0067
330 ABDOMINAL DISTENSION 703 0.0067
331 INFLUENZA 747 0.0067
332 RESPIRATORY TRACT INFECTION 174 0.0067
333 CARDIAC DISORDER 619 0.0066
334 LIVER FUNCTION TEST ABNORMAL 192 0.0066
335 CONDITION AGGRAVATED 2003 0.0066
336 PRODUCT SUPPLY ISSUE 47 0.0066
337 DEAFNESS UNILATERAL 36 0.0065
338 SWELLING 611 0.0065
339 BRAIN FOG 102 0.0065
340 DISEASE PROGRESSION 767 0.0065
341 DEVICE LEAKAGE 281 0.0065
342 MYALGIA 1097 0.0064
343 URINE OUTPUT DECREASED 56 0.0064
344 SKIN ULCER 165 0.0064
345 BLOOD MAGNESIUM DECREASED 55 0.0064
346 LIGAMENT SPRAIN 63 0.0064
347 ELECTROLYTE IMBALANCE 74 0.0064
348 PAIN IN EXTREMITY 1875 0.0064
349 HEPATIC ENCEPHALOPATHY 59 0.0063
350 CLOSTRIDIUM DIFFICILE INFECTION 138 0.0063
351 SLEEP APNOEA SYNDROME 120 0.0063
352 BLOOD ALKALINE PHOSPHATASE INCREASED 156 0.0063
353 ASPHYXIA 51 0.0062
354 MUSCLE STRAIN 54 0.0062
355 MIOSIS 50 0.0062
356 TRISMUS 32 0.0062
357 SLUGGISHNESS 63 0.0062
358 PHOTOPHOBIA 116 0.0062
359 DECREASED APPETITE 1427 0.0061
360 MOUTH HAEMORRHAGE 45 0.0061
361 HAEMOGLOBIN DECREASED 629 0.0061
362 HEART RATE IRREGULAR 138 0.0061
363 NASOPHARYNGITIS 1124 0.0061
364 MENTAL STATUS CHANGES 169 0.0061
365 LOSS OF CONSCIOUSNESS 776 0.0061
366 UNINTENTIONAL MEDICAL DEVICE REMOVAL 70 0.0060
367 PRODUCT DOSE OMISSION 393 0.0060
368 SEPSIS 668 0.0060
369 ABDOMINAL DISCOMFORT 1004 0.0060
370 HOT FLUSH 449 0.0060
371 END STAGE RENAL DISEASE 108 0.0059
372 WEIGHT DECREASED 1640 0.0059
373 PROCEDURAL COMPLICATION 45 0.0059
374 LIVER FUNCTION TEST INCREASED 126 0.0059
375 HYPERSOMNIA 168 0.0059
376 HYPOVOLAEMIA 34 0.0058
377 CARDIO-RESPIRATORY ARREST 242 0.0058
378 GASTROINTESTINAL HAEMORRHAGE 481 0.0057
379 HAEMATEMESIS 145 0.0057
380 TACHYCARDIA 508 0.0057
381 HEART RATE DECREASED 200 0.0057
382 TREATMENT NONCOMPLIANCE 311 0.0057
383 ARTHROPOD BITE 42 0.0057
384 EMPHYSEMA 57 0.0056
385 BLOOD SODIUM DECREASED 106 0.0056
386 WHEEZING 333 0.0056
387 DRUG INTOLERANCE 542 0.0056
388 RESTLESS LEGS SYNDROME 102 0.0056
389 BLOOD POTASSIUM INCREASED 91 0.0056
390 COVID-19 PNEUMONIA 66 0.0056
391 SUBDURAL HAEMATOMA 80 0.0056
392 UPPER GASTROINTESTINAL HAEMORRHAGE 94 0.0056
393 MYOPATHY 48 0.0056
394 LOWER GASTROINTESTINAL HAEMORRHAGE 41 0.0055
395 RIB FRACTURE 114 0.0055
396 DEHYDRATION 739 0.0055
397 FAECES DISCOLOURED 120 0.0055
398 DYSPEPSIA 541 0.0055
399 ASPARTATE AMINOTRANSFERASE INCREASED 292 0.0055
400 THERAPY CESSATION 281 0.0055
401 SMALL INTESTINAL OBSTRUCTION 67 0.0054
402 INTENTIONAL DOSE OMISSION 155 0.0054
403 NECK PAIN 303 0.0054
404 RENAL DISORDER 252 0.0054
405 VASCULITIS 63 0.0054
406 BEDRIDDEN 71 0.0054
407 PERIPHERAL COLDNESS 74 0.0054
408 POOR QUALITY SLEEP 116 0.0054
409 ASPIRATION 59 0.0054
410 POST PROCEDURAL COMPLICATION 103 0.0054
411 HYPERVENTILATION 31 0.0053
412 MUSCULOSKELETAL DISCOMFORT 92 0.0053
413 PNEUMONIA BACTERIAL 49 0.0053
414 BRONCHOSPASM 76 0.0053
415 NAUSEA 4199 0.0053
416 VOMITING 2491 0.0053
417 IMPAIRED GASTRIC EMPTYING 72 0.0053
418 UNRESPONSIVE TO STIMULI 136 0.0053
419 BRONCHITIS 390 0.0053
420 THERAPY INTERRUPTED 376 0.0053
421 INTERNATIONAL NORMALISED RATIO INCREASED 150 0.0053
422 ANOSMIA 76 0.0052
423 HAEMODIALYSIS 44 0.0052
424 LIMB INJURY 142 0.0052
425 TACHYPNOEA 71 0.0052
426 SNEEZING 117 0.0052
427 FATIGUE 4055 0.0052
428 TOOTH ABSCESS 53 0.0052
429 FRUSTRATION TOLERANCE DECREASED 42 0.0052
430 EAR INFECTION 138 0.0052
431 FEELING COLD 144 0.0052
432 OCULAR DISCOMFORT 58 0.0052
433 MIGRAINE 491 0.0051
434 MALAISE 2253 0.0051
435 BLOOD UREA INCREASED 86 0.0051
436 ACIDOSIS 39 0.0051
437 ALANINE AMINOTRANSFERASE INCREASED 313 0.0051
438 INGUINAL HERNIA 31 0.0051
439 MELAENA 112 0.0051
440 ORAL CANDIDIASIS 67 0.0051
441 FLATULENCE 287 0.0051
442 STAPHYLOCOCCAL INFECTION 166 0.0050
443 SCIATICA 80 0.0050
444 DEAFNESS 131 0.0050
445 ANAEMIA 954 0.0050
446 BACTERIAL INFECTION 93 0.0050
447 PETECHIAE 52 0.0050
448 BOWEL MOVEMENT IRREGULARITY 38 0.0050
449 RECTAL HAEMORRHAGE 212 0.0049
450 GASTROENTERITIS 72 0.0049
451 LIMB DISCOMFORT 152 0.0049
452 WEIGHT INCREASED 1100 0.0049
453 LARGE INTESTINE POLYP 34 0.0049
454 GASTROOESOPHAGEAL REFLUX DISEASE 394 0.0049
455 LUNG INFECTION 76 0.0049
456 DEVICE INFORMATION OUTPUT ISSUE 38 0.0049
457 PELVIC FRACTURE 38 0.0049
458 FEELING ABNORMAL 1167 0.0049
459 CARDIAC MURMUR 42 0.0048
460 ELECTROCARDIOGRAM ABNORMAL 38 0.0048
461 ISCHAEMIC STROKE 86 0.0048
462 POST PROCEDURAL HAEMORRHAGE 56 0.0048
463 ASTHENIA 1804 0.0048
464 LETHARGY 276 0.0048
465 FALL 1593 0.0048
466 ILLNESS 493 0.0048
467 PALLOR 130 0.0048
468 TINNITUS 218 0.0047
469 BACK PAIN 1102 0.0047
470 ABDOMINAL PAIN UPPER 976 0.0047
471 ACUTE KIDNEY INJURY 725 0.0047
472 GASTROINTESTINAL DISORDER 424 0.0047
473 BRADYCARDIA 251 0.0047
474 MULTIPLE ORGAN DYSFUNCTION SYNDROME 134 0.0047
475 CAESAREAN SECTION 55 0.0047
476 SEPTIC SHOCK 205 0.0047
477 DEATH 4027 0.0047
478 INTERSTITIAL LUNG DISEASE 226 0.0047
479 BLOOD PRESSURE FLUCTUATION 112 0.0047
480 CHOKING 91 0.0047
481 BLOOD CREATININE INCREASED 304 0.0047
482 ANURIA 40 0.0046
483 ANGINA PECTORIS 133 0.0046
484 HYPOKALAEMIA 214 0.0046
485 RENAL FAILURE 608 0.0046
486 EMBOLISM 38 0.0046
487 FEELING JITTERY 87 0.0046
488 LUNG INFILTRATION 40 0.0045
489 EAR PAIN 88 0.0045
490 AUTOIMMUNE DISORDER 44 0.0045
491 LIVER DISORDER 200 0.0045
492 TRANSIENT ISCHAEMIC ATTACK 152 0.0045
493 BLOOD COUNT ABNORMAL 68 0.0045
494 KIDNEY INFECTION 88 0.0045
495 ORTHOSTATIC HYPOTENSION 78 0.0045
496 BLOOD PRESSURE DIASTOLIC DECREASED 33 0.0045
497 HIP FRACTURE 143 0.0044
498 APHONIA 62 0.0044
499 ARRHYTHMIA 210 0.0044
500 GASTRIC HAEMORRHAGE 51 0.0044
501 DIPLOPIA 115 0.0044
502 HYPERTHYROIDISM 64 0.0044
503 VENTRICULAR FIBRILLATION 49 0.0044
504 DYSPHONIA 257 0.0044
505 SARS-COV-2 TEST POSITIVE 58 0.0044
506 NEPHROPATHY 41 0.0044
507 MALNUTRITION 49 0.0044
508 GALLBLADDER DISORDER 78 0.0044
509 SYSTEMIC LUPUS ERYTHEMATOSUS 155 0.0044
510 DRY MOUTH 354 0.0044
511 ANKLE FRACTURE 67 0.0043
512 POLLAKIURIA 180 0.0043
513 CEREBRAL HAEMORRHAGE 154 0.0043
514 DRUG ABUSE 358 0.0043
515 SUBSTANCE ABUSE 35 0.0043
516 SHOCK HAEMORRHAGIC 35 0.0043
517 DEVICE MALFUNCTION 301 0.0043
518 HYSTERECTOMY 37 0.0043
519 EYE HAEMORRHAGE 57 0.0043
520 SWELLING FACE 278 0.0043
521 COMA 203 0.0043
522 THIRST 76 0.0042
523 TOOTHACHE 77 0.0042
524 TOOTH INFECTION 56 0.0042
525 ACUTE MYOCARDIAL INFARCTION 125 0.0042
526 APNOEA 33 0.0042
527 DIVERTICULITIS 117 0.0042
528 CHOLECYSTECTOMY 48 0.0042
529 GENERAL PHYSICAL HEALTH DETERIORATION 486 0.0042
530 PSEUDOMONAS INFECTION 36 0.0042
531 CHILLS 492 0.0042
532 BLINDNESS 171 0.0042
533 TASTE DISORDER 85 0.0042
534 SCRATCH 44 0.0042
535 PULMONARY MASS 62 0.0042
536 HAEMORRHOIDS 81 0.0041
537 OBSTRUCTIVE AIRWAYS DISORDER 46 0.0041
538 PRODUCT USE ISSUE 774 0.0041
539 CHRONIC KIDNEY DISEASE 311 0.0041
540 FEEDING DISORDER 83 0.0041
541 PHARYNGEAL SWELLING 40 0.0041
542 DEVICE USE ERROR 142 0.0041
543 PNEUMONIA ASPIRATION 102 0.0041
544 PYREXIA 1411 0.0041
545 MUSCLE TIGHTNESS 66 0.0041
546 BLINDNESS TRANSIENT 30 0.0041
547 FEELING HOT 247 0.0040
548 HYPOACUSIS 173 0.0040
549 SINUS TACHYCARDIA 57 0.0040
550 LOSS OF LIBIDO 36 0.0040
551 SPINAL FRACTURE 80 0.0040
552 PERICARDITIS 67 0.0040
553 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 218 0.0040
554 BLINDNESS UNILATERAL 56 0.0040
555 MUSCULOSKELETAL PAIN 208 0.0040
556 UPPER LIMB FRACTURE 79 0.0040
557 LIP SWELLING 132 0.0040
558 COAGULOPATHY 66 0.0040
559 CLOSTRIDIUM DIFFICILE COLITIS 42 0.0040
560 HERNIA 76 0.0039
561 RESPIRATORY ARREST 108 0.0039
562 DEVICE ISSUE 351 0.0039
563 URINARY TRACT INFECTION 667 0.0039
564 NEURALGIA 95 0.0039
565 MALIGNANT MELANOMA 52 0.0039
566 TEMPERATURE INTOLERANCE 40 0.0039
567 COLD SWEAT 68 0.0039
568 AGEUSIA 96 0.0038
569 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 34 0.0038
570 ACUTE RESPIRATORY DISTRESS SYNDROME 68 0.0038
571 SINUSITIS 394 0.0038
572 HAEMORRHAGE 400 0.0038
573 LOWER RESPIRATORY TRACT INFECTION 174 0.0038
574 ATRIAL SEPTAL DEFECT 32 0.0038
575 FREQUENT BOWEL MOVEMENTS 103 0.0038
576 HYPOTONIA 38 0.0038
577 DRUG USE DISORDER 32 0.0038
578 GAIT INABILITY 127 0.0038
579 EXPOSURE DURING PREGNANCY 236 0.0038
580 INFECTION 549 0.0038
581 COVID-19 662 0.0038
582 NO THERAPEUTIC RESPONSE 46 0.0038
583 ULCER 60 0.0038
584 VISUAL IMPAIRMENT 466 0.0038
585 GASTRIC DISORDER 129 0.0038
586 BLOOD URINE PRESENT 71 0.0037
587 BODY TEMPERATURE INCREASED 76 0.0037
588 INTESTINAL OBSTRUCTION 140 0.0037
589 INSOMNIA 989 0.0037
590 JOINT SWELLING 448 0.0037
591 MITRAL VALVE INCOMPETENCE 42 0.0037
592 EATING DISORDER 79 0.0037
593 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 178 0.0037
594 HAEMATOCHEZIA 204 0.0037
595 CHOLECYSTITIS 44 0.0037
596 GENERALISED TONIC-CLONIC SEIZURE 61 0.0037
597 ARTHRALGIA 1523 0.0037
598 HEMIPARESIS 62 0.0037
599 GROIN PAIN 32 0.0036
600 FOETAL EXPOSURE DURING PREGNANCY 292 0.0036
601 BRAIN INJURY 36 0.0036
602 LACRIMATION INCREASED 108 0.0036
603 MUSCLE SPASMS 656 0.0036
604 HYPERBILIRUBINAEMIA 37 0.0036
605 JAUNDICE 96 0.0036
606 THROMBOSIS 287 0.0036
607 GAMMA-GLUTAMYLTRANSFERASE INCREASED 79 0.0036
608 HYPERKALAEMIA 125 0.0036
609 JOINT INJURY 76 0.0036
610 ANXIETY 1012 0.0036
611 TENDERNESS 37 0.0035
612 HEPATIC FAILURE 107 0.0035
613 PHARYNGITIS 44 0.0035
614 DRUG INTERACTION 562 0.0035
615 ANHEDONIA 93 0.0035
616 DEPRESSED MOOD 187 0.0035
617 RED BLOOD CELL COUNT DECREASED 101 0.0035
618 DIARRHOEA HAEMORRHAGIC 33 0.0035
619 RENAL IMPAIRMENT 296 0.0035
620 MYOCARDIAL ISCHAEMIA 40 0.0035
621 LACERATION 33 0.0035
622 ABDOMINAL PAIN 816 0.0035
623 CANDIDA INFECTION 59 0.0035
624 DEVICE USE ISSUE 61 0.0035
625 FOOT FRACTURE 66 0.0035
626 GASTROINTESTINAL INFECTION 31 0.0035
627 INJECTION SITE IRRITATION 44 0.0035
628 CONSTIPATION 752 0.0034
629 HEAVY MENSTRUAL BLEEDING 31 0.0034
630 PAIN 2116 0.0034
631 MUSCULAR WEAKNESS 391 0.0034
632 ECONOMIC PROBLEM 52 0.0034
633 MYDRIASIS 44 0.0034
634 POISONING 43 0.0034
635 PHARYNGITIS STREPTOCOCCAL 37 0.0034
636 WHITE BLOOD CELL COUNT INCREASED 131 0.0034
637 VISION BLURRED 468 0.0034
638 BRAIN OEDEMA 43 0.0034
639 BACK INJURY 37 0.0034
640 OVARIAN CYST 34 0.0034
641 HIP ARTHROPLASTY 52 0.0034
642 INCREASED TENDENCY TO BRUISE 31 0.0034
643 GINGIVAL BLEEDING 46 0.0034
644 EYE INFECTION 38 0.0034
645 CYSTITIS 107 0.0034
646 HERPES ZOSTER 193 0.0034
647 LABORATORY TEST ABNORMAL 99 0.0034
648 PLATELET COUNT DECREASED 357 0.0033
649 GASTRITIS 88 0.0033
650 PRODUCT DISTRIBUTION ISSUE 31 0.0033
651 LOWER LIMB FRACTURE 64 0.0033
652 HAEMATOMA 86 0.0033
653 OSTEOMYELITIS 60 0.0033
654 FULL BLOOD COUNT ABNORMAL 35 0.0033
655 HYPERHIDROSIS 425 0.0033
656 ABORTION INDUCED 31 0.0033
657 WOUND INFECTION 36 0.0033
658 RASH PRURITIC 178 0.0033
659 BLOOD PRESSURE SYSTOLIC INCREASED 64 0.0033
660 RENAL TUBULAR NECROSIS 32 0.0033
661 SPLENOMEGALY 38 0.0032
662 MICTURITION URGENCY 37 0.0032
663 PANIC ATTACK 118 0.0032
664 CHOLELITHIASIS 106 0.0032
665 TREMOR 535 0.0032
666 PRODUCT ADMINISTRATION ERROR 65 0.0032
667 APPENDICITIS 30 0.0032
668 SKIN DISCOLOURATION 147 0.0032
669 CHROMATURIA 72 0.0032
670 MULTI-ORGAN FAILURE 55 0.0032
671 CARDIOMYOPATHY 47 0.0032
672 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 54 0.0032
673 GLOMERULAR FILTRATION RATE DECREASED 39 0.0032
674 CONTUSION 305 0.0032
675 HIATUS HERNIA 41 0.0032
676 OSTEOPENIA 48 0.0032
677 INTENTIONAL PRODUCT USE ISSUE 277 0.0032
678 HYPOGLYCAEMIA 153 0.0032
679 ERUCTATION 61 0.0031
680 DYSSTASIA 92 0.0031
681 HAEMORRHAGE INTRACRANIAL 47 0.0031
682 BLOOD TEST ABNORMAL 44 0.0031
683 QUALITY OF LIFE DECREASED 42 0.0031
684 IMPAIRED QUALITY OF LIFE 45 0.0031
685 DYSURIA 115 0.0031
686 JOINT DISLOCATION 33 0.0031
687 INABILITY TO AFFORD MEDICATION 31 0.0031
688 OCULAR HYPERAEMIA 148 0.0031
689 ROTATOR CUFF SYNDROME 40 0.0031
690 BONE PAIN 182 0.0031
691 TUBULOINTERSTITIAL NEPHRITIS 58 0.0031
692 SCAB 35 0.0031
693 PRODUCT SUBSTITUTION ISSUE 174 0.0030
694 DERMATITIS ALLERGIC 38 0.0030
695 OBESITY 48 0.0030
696 NERVOUSNESS 157 0.0030
697 THROAT TIGHTNESS 81 0.0030
698 HYPERTENSION 631 0.0030
699 ARTHRITIS 234 0.0030
700 TOOTH EXTRACTION 37 0.0030
701 HYPOPHAGIA 76 0.0030
702 SOMNOLENCE 597 0.0030
703 MUSCLE TWITCHING 68 0.0029
704 EXTRA DOSE ADMINISTERED 118 0.0029
705 EYE PAIN 164 0.0029
706 ORAL PAIN 65 0.0029
707 HEPATIC STEATOSIS 54 0.0029
708 APATHY 42 0.0029
709 GAIT DISTURBANCE 551 0.0029
710 SHOCK 66 0.0029
711 WOUND 80 0.0029
712 PRODUCT DOSE OMISSION IN ERROR 81 0.0029
713 PRODUCT USE COMPLAINT 45 0.0029
714 ACUTE HEPATIC FAILURE 39 0.0029
715 ANGIOEDEMA 126 0.0028
716 MACULAR DEGENERATION 34 0.0028
717 FACE OEDEMA 48 0.0028
718 ERYTHEMA 585 0.0028
719 OSTEOPOROSIS 117 0.0028
720 ACCIDENTAL OVERDOSE 104 0.0028
721 MUSCLE ATROPHY 36 0.0028
722 DEVICE BREAKAGE 115 0.0028
723 MEMORY IMPAIRMENT 388 0.0028
724 EYE SWELLING 105 0.0028
725 COLON CANCER 42 0.0028
726 PRODUCT DOSE OMISSION ISSUE 826 0.0028
727 MANIA 46 0.0028
728 RHABDOMYOLYSIS 116 0.0028
729 SLEEP DISORDER 196 0.0028
730 RASH MACULAR 97 0.0028
731 SEIZURE 320 0.0028
732 ENCEPHALOPATHY 68 0.0028
733 SKIN REACTION 39 0.0028
734 ABSCESS 44 0.0028
735 GLAUCOMA 53 0.0027
736 SCAR 47 0.0027
737 OFF LABEL USE 2399 0.0027
738 CONFUSIONAL STATE 441 0.0027
739 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 194 0.0027
740 MATERNAL EXPOSURE DURING PREGNANCY 243 0.0027
741 PARANOIA 47 0.0027
742 DISORIENTATION 108 0.0027
743 THYROID DISORDER 42 0.0027
744 BLOOD PRESSURE INCREASED 416 0.0027
745 HYPOAESTHESIA ORAL 41 0.0027
746 CARPAL TUNNEL SYNDROME 38 0.0027
747 PARAESTHESIA ORAL 39 0.0027
748 ROAD TRAFFIC ACCIDENT 113 0.0027
749 INTENTIONAL PRODUCT MISUSE 236 0.0027
750 VERTIGO 164 0.0027
751 AGITATION 197 0.0027
752 NIGHT SWEATS 86 0.0027
753 HYPOMAGNESAEMIA 37 0.0027
754 NEPHROLITHIASIS 121 0.0026
755 NOCTURIA 32 0.0026
756 HAEMATURIA 90 0.0026
757 PLATELET COUNT INCREASED 34 0.0026
758 DRUG DOSE OMISSION 430 0.0026
759 PAIN OF SKIN 70 0.0026
760 DIABETES MELLITUS INADEQUATE CONTROL 46 0.0026
761 HYPERLIPIDAEMIA 31 0.0026
762 EYE PRURITUS 87 0.0026
763 PULMONARY EMBOLISM 246 0.0026
764 AMNESIA 168 0.0026
765 CORONARY ARTERY DISEASE 78 0.0026
766 INFLUENZA LIKE ILLNESS 212 0.0026
767 BLOOD CREATINE PHOSPHOKINASE INCREASED 74 0.0026
768 TRANSAMINASES INCREASED 57 0.0026
769 PREGNANCY 51 0.0025
770 SURGERY 149 0.0025
771 FULL BLOOD COUNT DECREASED 51 0.0025
772 DISTURBANCE IN ATTENTION 136 0.0025
773 BACK DISORDER 41 0.0025
774 HEPATOTOXICITY 56 0.0025
775 ACCIDENT 30 0.0025
776 CATARACT 149 0.0025
777 INSURANCE ISSUE 38 0.0025
778 DEVICE ADHESION ISSUE 38 0.0025
779 HYPONATRAEMIA 139 0.0025
780 SKIN IRRITATION 113 0.0025
781 DRUG INEFFECTIVE 3249 0.0025
782 HEPATIC FUNCTION ABNORMAL 92 0.0025
783 ABDOMINAL PAIN LOWER 62 0.0024
784 ORAL DISCOMFORT 34 0.0024
785 EJECTION FRACTION DECREASED 38 0.0024
786 LIVER INJURY 60 0.0024
787 METABOLIC ACIDOSIS 78 0.0024
788 MYOCARDIAL INFARCTION 425 0.0024
789 HEPATIC ENZYME INCREASED 166 0.0024
790 URINARY INCONTINENCE 72 0.0024
791 LYMPHADENOPATHY 86 0.0024
792 SKIN HAEMORRHAGE 36 0.0024
793 C-REACTIVE PROTEIN INCREASED 88 0.0024
794 BLOOD GLUCOSE DECREASED 116 0.0024
795 SKIN DISORDER 80 0.0024
796 ADVERSE EVENT 220 0.0024
797 BURNING SENSATION 167 0.0024
798 DISCOMFORT 145 0.0024
799 THROMBOCYTOPENIA 265 0.0024
800 DRUG EFFECT LESS THAN EXPECTED 35 0.0024
801 DRUG LEVEL INCREASED 39 0.0024
802 LOCAL SWELLING 41 0.0023
803 BLISTER 132 0.0023
804 EYE DISORDER 77 0.0023
805 HYPOAESTHESIA 350 0.0023
806 COGNITIVE DISORDER 109 0.0023
807 NEUROPATHY PERIPHERAL 222 0.0023
808 RENAL FAILURE ACUTE 99 0.0023
809 PARAESTHESIA 367 0.0023
810 PRODUCT PHYSICAL ISSUE 47 0.0023
811 BALANCE DISORDER 201 0.0023
812 DIABETES MELLITUS 177 0.0023
813 MENTAL DISORDER 100 0.0023
814 MENORRHAGIA 45 0.0023
815 CEREBROVASCULAR ACCIDENT 388 0.0023
816 DEMENTIA 64 0.0023
817 HYPOKINESIA 33 0.0023
818 TOXICITY TO VARIOUS AGENTS 383 0.0023
819 PANCREATITIS 120 0.0023
820 CONTRAINDICATED PRODUCT ADMINISTERED 68 0.0022
821 KNEE ARTHROPLASTY 47 0.0022
822 DYSPHAGIA 211 0.0022
823 RASH 967 0.0022
824 MASS 31 0.0022
825 RASH ERYTHEMATOUS 106 0.0022
826 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 38 0.0022
827 GASTRIC ULCER 42 0.0022
828 SEROTONIN SYNDROME 42 0.0022
829 PANCREATITIS ACUTE 49 0.0022
830 SWOLLEN TONGUE 68 0.0022
831 DEPRESSION 495 0.0022
832 PNEUMONITIS 59 0.0022
833 MOOD ALTERED 59 0.0022
834 FUNGAL INFECTION 72 0.0022
835 SPEECH DISORDER 112 0.0021
836 RESTLESSNESS 78 0.0021
837 RENAL INJURY 63 0.0021
838 APHASIA 64 0.0021
839 TOOTH DISORDER 47 0.0021
840 IRRITABLE BOWEL SYNDROME 45 0.0021
841 DYSARTHRIA 79 0.0021
842 HALLUCINATION 158 0.0021
843 THERAPEUTIC RESPONSE UNEXPECTED 94 0.0021
844 SICKLE CELL ANAEMIA WITH CRISIS 33 0.0021
845 PRURITUS 799 0.0021
846 ALTERED STATE OF CONSCIOUSNESS 45 0.0021
847 HALLUCINATION, AUDITORY 33 0.0021
848 OSTEOARTHRITIS 88 0.0021
849 DRUG-INDUCED LIVER INJURY 65 0.0021
850 PHOTOSENSITIVITY REACTION 34 0.0021
851 COLITIS 78 0.0021
852 BASAL CELL CARCINOMA 32 0.0020
853 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 366 0.0020
854 INTENTIONAL OVERDOSE 130 0.0020
855 URINARY RETENTION 67 0.0020
856 IRRITABILITY 120 0.0020
857 ASTHMA 225 0.0020
858 PANCYTOPENIA 110 0.0020
859 HYPERSENSITIVITY 363 0.0020
860 LEUKOCYTOSIS 35 0.0019
861 MUSCULOSKELETAL STIFFNESS 169 0.0019
862 CEREBRAL INFARCTION 47 0.0019
863 PROCEDURAL PAIN 53 0.0019
864 ARTHROPATHY 106 0.0019
865 CRYING 69 0.0019
866 LUNG NEOPLASM MALIGNANT 78 0.0019
867 CONJUNCTIVITIS 35 0.0019
868 PRODUCT PRESCRIBING ISSUE 41 0.0019
869 MIDDLE INSOMNIA 35 0.0019
870 NEOPLASM MALIGNANT 125 0.0019
871 DEPRESSED LEVEL OF CONSCIOUSNESS 74 0.0019
872 BONE DISORDER 34 0.0019
873 PRESCRIBED OVERDOSE 36 0.0019
874 INFLAMMATION 96 0.0019
875 MOBILITY DECREASED 133 0.0018
876 MOUTH ULCERATION 39 0.0018
877 GYNAECOMASTIA 57 0.0018
878 INTERVERTEBRAL DISC PROTRUSION 40 0.0018
879 RASH PAPULAR 41 0.0018
880 ADVERSE DRUG REACTION 161 0.0018
881 HYPERGLYCAEMIA 65 0.0018
882 GLYCOSYLATED HAEMOGLOBIN INCREASED 45 0.0018
883 ILL-DEFINED DISORDER 107 0.0018
884 TYPE 2 DIABETES MELLITUS 59 0.0018
885 HYPOCALCAEMIA 33 0.0017
886 THERAPEUTIC PRODUCT EFFECT DECREASED 78 0.0017
887 TOOTH LOSS 36 0.0017
888 APPLICATION SITE PRURITUS 39 0.0017
889 INCORRECT DOSE ADMINISTERED 392 0.0017
890 SKIN LESION 47 0.0017
891 FEMUR FRACTURE 53 0.0017
892 FEAR 46 0.0017
893 EXPOSURE VIA SKIN CONTACT 44 0.0017
894 PRODUCT PRESCRIBING ERROR 40 0.0017
895 DRY SKIN 223 0.0017
896 DERMATITIS 35 0.0017
897 DYSGEUSIA 124 0.0017
898 DEEP VEIN THROMBOSIS 105 0.0016
899 CHOLESTASIS 31 0.0016
900 DELIRIUM 56 0.0016
901 COMPLETED SUICIDE 134 0.0016
902 AGGRESSION 80 0.0016
903 PRODUCT USE IN UNAPPROVED INDICATION 396 0.0016
904 SKIN FISSURES 31 0.0016
905 PRODUCT AVAILABILITY ISSUE 36 0.0016
906 MENTAL IMPAIRMENT 38 0.0016
907 DISABILITY 31 0.0016
908 APPLICATION SITE ERYTHEMA 41 0.0016
909 HALLUCINATION, VISUAL 33 0.0016
910 IMPAIRED HEALING 51 0.0016
911 HEPATITIS 39 0.0015
912 BLOOD CHOLESTEROL INCREASED 71 0.0015
913 PRODUCT PREPARATION ERROR 31 0.0015
914 INJURY 106 0.0015
915 MOOD SWINGS 48 0.0015
916 DRY EYE 75 0.0015
917 INJECTION SITE RASH 46 0.0015
918 SKIN CANCER 32 0.0015
919 LACTIC ACIDOSIS 48 0.0015
920 PRURITUS GENERALISED 32 0.0015
921 VISUAL ACUITY REDUCED 49 0.0015
922 NIGHTMARE 51 0.0015
923 EYE IRRITATION 84 0.0015
924 INJECTION SITE PRURITUS 97 0.0014
925 INJECTION SITE ERYTHEMA 178 0.0014
926 PRODUCT DISPENSING ERROR 31 0.0014
927 JOINT STIFFNESS 37 0.0014
928 SUICIDAL IDEATION 129 0.0014
929 FIBROMYALGIA 34 0.0014
930 URTICARIA 232 0.0014
931 OVERDOSE 298 0.0014
932 CARDIOVASCULAR DISORDER 35 0.0014
933 BLOOD GLUCOSE INCREASED 259 0.0014
934 ABNORMAL BEHAVIOUR 54 0.0014
935 EMOTIONAL DISORDER 42 0.0014
936 VAGINAL HAEMORRHAGE 58 0.0013
937 THERAPEUTIC RESPONSE DECREASED 79 0.0013
938 BONE DENSITY DECREASED 40 0.0013
939 DEVICE DIFFICULT TO USE 84 0.0013
940 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 256 0.0013
941 EMOTIONAL DISTRESS 152 0.0013
942 STOMATITIS 76 0.0013
943 EPILEPSY 38 0.0012
944 WHITE BLOOD CELL COUNT DECREASED 134 0.0012
945 RASH GENERALISED 32 0.0012
946 COLITIS ULCERATIVE 55 0.0012
947 DYSKINESIA 50 0.0012
948 ELECTROCARDIOGRAM QT PROLONGED 44 0.0012
949 ANAPHYLACTIC REACTION 67 0.0012
950 ANGER 41 0.0012
951 SUICIDE ATTEMPT 73 0.0012
952 DRUG EFFECT INCOMPLETE 43 0.0012
953 SKIN EXFOLIATION 99 0.0012
954 EXPIRED PRODUCT ADMINISTERED 39 0.0012
955 DRUG ADMINISTRATION ERROR 36 0.0012
956 NEEDLE ISSUE 34 0.0012
957 UNDERDOSE 85 0.0012
958 PSYCHOTIC DISORDER 34 0.0012
959 HYPOTHYROIDISM 36 0.0011
960 INJECTION SITE SWELLING 86 0.0011
961 OSTEONECROSIS 36 0.0011
962 TREATMENT FAILURE 89 0.0011
963 PLASMA CELL MYELOMA 41 0.0010
964 ALOPECIA 205 0.0010
965 INJECTION SITE HAEMORRHAGE 83 0.0010
966 PSORIATIC ARTHROPATHY 42 0.0010
967 MOVEMENT DISORDER 32 0.0010
968 DISEASE RECURRENCE 47 0.0010
969 INJECTION SITE PAIN 299 0.0010
970 ECZEMA 51 0.0010
971 PROSTATE CANCER 77 0.0010
972 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 44 0.0009
973 RHEUMATOID ARTHRITIS 103 0.0009
974 MEDICATION ERROR 50 0.0009
975 CONVULSION 47 0.0008
976 SKIN BURNING SENSATION 58 0.0008
977 INFUSION RELATED REACTION 53 0.0008
978 DERMATITIS ATOPIC 42 0.0008
979 ACCIDENTAL EXPOSURE TO PRODUCT 78 0.0008
980 FEBRILE NEUTROPENIA 49 0.0007
981 PRODUCT QUALITY ISSUE 97 0.0007
982 PSORIASIS 93 0.0007
983 INJECTION SITE BRUISING 56 0.0007
984 NO ADVERSE EVENT 121 0.0007
985 MULTIPLE SCLEROSIS 31 0.0006
986 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 46 0.0006
987 INJECTION SITE REACTION 44 0.0006
988 BLADDER CANCER 37 0.0006
989 BREAST CANCER 49 0.0005
990 DRUG WITHDRAWAL SYNDROME 46 0.0005
991 ACNE 38 0.0005
992 MULTIPLE SCLEROSIS RELAPSE 33 0.0005
993 DRUG DEPENDENCE 70 0.0004
994 NEUTROPENIA 47 0.0003